Pemirolast
From Wikidoc - Reading time: 2 min | |
| Clinical data | |
|---|---|
| Trade names | Alamast |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | Oral, ophthalmic |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H8N6O |
| Molar mass | 228.21 g/mol |
| 3D model (JSmol) | |
| |
  (what is this?) (verify) | |
|
WikiDoc Resources for Pemirolast |
|
Articles |
|---|
|
Most recent articles on Pemirolast |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Pemirolast at Clinical Trials.gov Clinical Trials on Pemirolast at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Pemirolast
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Pemirolast Discussion groups on Pemirolast Patient Handouts on Pemirolast Directions to Hospitals Treating Pemirolast Risk calculators and risk factors for Pemirolast
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Pemirolast |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview[edit | edit source]
Pemirolast (INN) is a mast cell stabilizer used as an anti-allergic drug therapy. It is marketed under the tradenames Alegysal and Alamast.
It has also been studied for the treatment of asthma.
References[edit | edit source]
Original source: https://wikidoc.org/Pemirolast
Status: article is cached
EncycloReader
is supported by the 
KSF